TuHURA Biosciences, Inc. HURA Payments Of Merger Related Costs Financing Activities
Payments Of Merger Related Costs Financing Activities at other companies
Other financials
Where this comes from
Reported directly by TuHURA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities.
The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about TuHURA Biosciences, Inc.'s payments of merger related costs financing activities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TuHURA Biosciences, Inc.'s payments of merger related costs financing activities?
- TuHURA Biosciences, Inc. (HURA) reported payments of merger related costs financing activities of $500K in Q1 2025.
- How has TuHURA Biosciences, Inc.'s payments of merger related costs financing activities changed year-over-year?
- TuHURA Biosciences, Inc.'s payments of merger related costs financing activities decreased by 44.9% year-over-year, from $907.42K to $500K.
- What does payments of merger related costs financing activities mean?
- This tracks cash outflows specifically associated with the financing aspects of a merger or acquisition, such as advisory fees or debt restructuring costs related to the deal. It provides insight into the total transaction costs required to execute corporate growth strategies.